Clinical Trial Update: Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating limited adjuvant endocrine therapy for low-risk breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Breast Cancer Female, Hormone Receptor Positive Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING